As of 2025-07-01, the EV/EBITDA ratio of Fortress Biotech Inc (FBIO) is -0.24. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FBIO's latest enterprise value is 20.74 mil USD. FBIO's TTM EBITDA according to its financial statements is -87.43 mil USD. Dividing these 2 quantities gives us the above FBIO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 12.5x | 12.4x |
| Forward P/E multiples | 20.2x - 43.4x | 31.8x |
| Fair Price | (58.61) - (35.84) | (64.30) |
| Upside | -3320.2% - -2069.3% | -3633.0% |
| Date | EV/EBITDA |
| 2025-06-26 | -0.25 |
| 2025-06-25 | -0.23 |
| 2025-06-24 | -0.23 |
| 2025-06-23 | -0.20 |
| 2025-06-20 | -0.22 |
| 2025-06-18 | -0.23 |
| 2025-06-17 | -0.24 |
| 2025-06-16 | -0.24 |
| 2025-06-13 | -0.25 |
| 2025-06-12 | -0.28 |
| 2025-06-11 | -0.33 |
| 2025-06-10 | -0.33 |
| 2025-06-09 | -0.34 |
| 2025-06-06 | -0.30 |
| 2025-06-05 | -0.26 |
| 2025-06-04 | -0.25 |
| 2025-06-03 | -0.24 |
| 2025-06-02 | -0.24 |
| 2025-05-30 | -0.26 |
| 2025-05-29 | -0.28 |
| 2025-05-28 | -0.26 |
| 2025-05-27 | -0.24 |
| 2025-05-23 | -0.22 |
| 2025-05-22 | -0.21 |
| 2025-05-21 | -0.20 |
| 2025-05-20 | -0.21 |
| 2025-05-19 | -0.22 |
| 2025-05-16 | -0.23 |
| 2025-05-15 | -0.22 |
| 2025-05-14 | -0.18 |
| 2025-05-13 | -0.21 |
| 2025-05-12 | -0.18 |
| 2025-05-09 | -0.19 |
| 2025-05-08 | -0.19 |
| 2025-05-07 | -0.20 |
| 2025-05-06 | -0.21 |
| 2025-05-05 | -0.22 |
| 2025-05-02 | -0.24 |
| 2025-05-01 | -0.21 |
| 2025-04-30 | -0.22 |
| 2025-04-29 | -0.21 |
| 2025-04-28 | -0.19 |
| 2025-04-25 | -0.18 |
| 2025-04-24 | -0.18 |
| 2025-04-23 | -0.16 |
| 2025-04-22 | -0.14 |
| 2025-04-21 | -0.13 |
| 2025-04-17 | -0.14 |
| 2025-04-16 | -0.13 |
| 2025-04-15 | -0.14 |